Drugmaker Group Boosts Lobbying as Push to Lower Prices Stalls

(Bloomberg) -- The drug industry’s primary trade group increased its spending on lobbying during the second quarter, as President Donald Trump’s promised efforts to lower the prices of prescription...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.